TB-500: Clinical Trials & Research
10 registered clinical trials and 44 peer-reviewed publications indexed for TB-500, sourced from ClinicalTrials.gov and PubMed.
Clinical trials
- Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
- TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
- Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
- Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction
- Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
Research papers
- Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 ×…
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
- Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals
- Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by…
See also: TB-500 full profile.